首页 | 本学科首页   官方微博 | 高级检索  
     

肝癌复发转移再切除治疗的疗效分析(附30例报告)
引用本文:武金才,张建军,陆才德,戴德坚. 肝癌复发转移再切除治疗的疗效分析(附30例报告)[J]. 外科理论与实践, 2002, 7(4): 289-290
作者姓名:武金才  张建军  陆才德  戴德坚
作者单位:1. 浙江大学医学院附属二院普外科,310009
2. 江西省贵溪市人民医院,335400
摘    要:目的:评价再手术在肝癌复发治疗中的地位。方法:回顾分析1988年-1999年30例肝癌复发再手术切除的随访资料。结果:首次手术后1,2,3年和5年总生存率分别为93.3%,73.3%,56.7%和36.7%。第一次再手术后1,3和5年生存率分别为63.3%,23.3%和13.3%,肺叶切除后1,3和5年生存率分别为71.4%,42.9%和28.6%。结论:肝癌复发病人再手术后的预后与复发时肿瘤大小,数目,类型相关,再切除是肝癌复发的首选治疗方法。

关 键 词:肝癌 复发 再手术 治疗
文章编号:1007-9610(2002)04-0289-02
修稿时间:2001-12-07

Analysis of Effects in Re-resection for Recurrent Hepatocellular Carcinoma(a Report of 30 Cases)
WU Jincai ,ZHANG Jianjun ,LU Caide,et al.. Analysis of Effects in Re-resection for Recurrent Hepatocellular Carcinoma(a Report of 30 Cases)[J]. Journal of Surgery Concepts & Practice, 2002, 7(4): 289-290
Authors:WU Jincai   ZHANG Jianjun   LU Caide  et al.
Abstract:To evaluate re resection in the treatment of recurrent hepatocellular carcinoma. Methods: Thirty patients with recurrent hepatocarcinoma re resected were followed up and thire post operative survival data were analyzed. Results:The sur vival rate of 1, 2, 3 and 5 year in the 30 cases were 93.3%, 73.3%, 56.7% and 36.7% respectively, with the median survival term of 18.5 months, and average of 26.0 months. The preliminary results were encouraging. Conclusions: The size and pathological type of recurrent hepatocarcinoma are factors influencing the prognosis of patients. Re resection of recurrent HCC could markedly prolong the patients' survival term.
Keywords:Hepatocarcinoma Recurrence Hepatectomy
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号